Genic

123330KOSDAQMaterialsTrading normally
US$13.42
▼ −US$0.20 (−1.50%)Close · 2026-10-21
Share price
▼ −14.1%over 1y
25/1026/0126/0426/0726/10
$15$20$25

Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.

What the company does

Genic makes skin-care face masks, thin sheets or gel patches applied to the face to moisturise and treat skin, along with broader skin-care products such as creams and essences.

It supplies both under its own brands, including Celderma, and as a contract manufacturer (OEM/ODM) for global beauty companies. Listed on KOSDAQ, Korea's tech and small-cap board, the company earns the majority of its revenue from its hydrogel mask pack, a water-soluble gel format for which it holds manufacturing patents.

Summary is AI-generated and may contain errors · figures from DART filings

KEY FACTS
Market capUS$106.4M
SectorMaterials
SubsectorChemicals
MarketKOSDAQ
Cap tierSmall-cap
Financials
10Y · FY2016~2025 · USD
Revenue
US$59MFY2025 · latest
'16'20'25
low US$21.2Mhigh US$67.7M
Operating profit
US$11.3MFY2025 · latest
'16'20'25
low −US$8.6Mhigh US$11.3M
● red = loss year
Net income
US$14.3MFY2025 · latest
'16'20'25
low −US$11.6Mhigh US$14.3M
● red = loss year
Hover or tap a year for its figure · red dot = loss year · latest FY2025
Why it matters · Context, not a recommendation

Genic holds patents on its core water-soluble hydrogel mask-pack manufacturing technology, giving it a proprietary production process rather than relying on off-the-shelf methods.

Quick answers

Genic in five facts

What does Genic do?

Genic makes skin-care face masks, thin sheets or gel patches applied to the face to moisturise and treat skin, along with broader skin-care products such as creams and essences.

Where is Genic listed and in which sector?

Genic (Korean name: 제닉) trades under KRX code 123330 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Materials sector, Chemicals.

How large is Genic?

Its market capitalisation was US$106.4M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).

What were Genic's latest annual revenue and operating profit?

For fiscal year 2025, Genic reported revenue of US$59M, operating profit of US$11.3M and net income of US$14.3M, per its annual report on DART (data retrieved from DART on 2026-09-17). Revenue was up 56.7% on the previous year.

Where does this data come from?

Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.

Data sources

Data sources and last updated

Filings and financial statements
DART (dart.fss.or.kr), Korea's official corporate-filing system
Prices, market cap, trading status
KRX (Korea Exchange), via FinanceDataReader
Latest annual financials
Fiscal year 2025, data retrieved from DART on 2026-09-17
Share price and market cap
Close of 2026-10-21
Currency
US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
Company data updated
2026-10-21
Company summary
AI-generated from filings; may contain errors. Information only, not investment advice.